Delivery Order SPE2DB22D3102-SPE2DB26FK8SW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,441.60 to AmerisourceBergen Drug Corp for IPOL Vial 5ML, an inactivated polio vaccine product. Issued on April 24, 2025, with completion scheduled for April 25, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,652.21 to AmerisourceBergen Drug Corp for IPOL vial 5ML, a poliomyelitis vaccine product. The contract, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, is a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a competitive procurement action under an existing contract...
- The Defense Logistics Agency awarded a $5,450.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of IPOL vial 5ML, an inactivated polio vaccine. This competitively awarded, non-set-aside contract represents a routine pharmaceutical procurement supporting military medical supply requirements. The delivery order is scheduled for completion by June 9, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- This delivery order, valued at $72,979.90 with an ultimate completion date of November 3, 2025, was awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of IPOL Vial 5ML, a polio vaccine product. The contract employs firm fixed pricing and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of IPOL Vial 5ML, a poliomyelitis vaccine product. This firm fixed-price delivery order, valued at $1,526.14, represents a non-competitive award and is categorized as a child contract under AmerisourceBergen's larger federal contract vehicle. The order is scheduled for completion by August 19, 2025, with performance at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $54,368.42 to AmerisourceBergen Drug Corp for the supply of IPOL vial 5ML, a poliomyelitis vaccine product. This firm fixed price, competitively awarded delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for 5mL IPOL vials on July 14, 2025, with an ultimate completion date of July 15, 2025. IPOL is an inactivated polio vaccine commonly used by the Department of Defense and other federal healthcare systems for immunization programs. This competitively awarded, non-set-aside contract reflects a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of IPOL Vial 5ML, a polio vaccine product. This competitively awarded, non-set-aside contract carries a ceiling value of $52,324.80 and is structured as a firm fixed price delivery order with an ultimate completion date of September 29, 2025. The contractor will perform this work at its Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a $53.6K delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for supply of Ipol Vial 5ML, a polio vaccine product. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 8, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999M and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $2,180.20 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Ipol Vial 5ML, a polio vaccine product. This is a firm fixed price, non-competitive delivery order with a completion date of May 28, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under a larger vehicle—AmerisourceBergen's Indefinite Delivery...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB26FK8SWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for IPOL vial 5ML, an inactivated polio vaccine product. The contract is a firm fixed price delivery order with an ultimate completion date of October 29, 2025, and represents a non-set-aside competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The IDC serves as a prime vendor agreement enabling AmerisourceBergen to supply a wide range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs globally. Through this vehicle, the company fulfills medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with this particular order contributing to the DLA's vaccine and immunization supply requirements for military operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/28/25 |